Nabi Biopharmaceuticals (NABI) Reports Q1 Loss of $0.03/Share
Tweet Send to a FriendGet Alerts NABI Hot Sheet
Price: $1.80 --0%
EPS Growth %: -71.4%
Financial Fact:
Operating income (loss): 30K
Today's EPS Names:
TARO, SENEA, UQM, More
EPS Growth %: -71.4%
Financial Fact:
Operating income (loss): 30K
Today's EPS Names:
TARO, SENEA, UQM, More
Trade NABI Now!
Nabi Biopharmaceuticals (NASDAQ: NABI) reported Q1 EPS of ($0.03), versus $0.05 reported last year. Revenue for the quarter came in at $600 thousand, versus $9.17 million reported last year.
For earnings history and earnings-related data on Nabi Biopharmaceuticals (NABI) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Nabi Biopharmaceuticals (NABI) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- salesforce.com, Inc. (CRM) Reports In-Line Q1 EPS; Issues In-Line Q2, FY14 Outlook
- UPDATE: Intuit, Inc. (INTU) Tops Q3 EPS by 4c, Offers Guidance
- Marvell Technology Group (MRVL) Tops Q1 EPS by 5c; Issues Solid Outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
